Sangamo Therapeutics Stock Price History
| SGMO Stock | USD 0.84 0.03 3.45% |
Below is the normalized historical share price chart for Sangamo Therapeutics extending back to April 06, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sangamo Therapeutics stands at 0.84, as last reported on the 21st of March, with the highest price reaching 0.92 and the lowest price hitting 0.82 during the day.
If you're considering investing in Sangamo Stock, it is important to understand the factors that can impact its price. Sangamo Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12 % return per unit of risk over the last 3 months. Sangamo Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sangamo Therapeutics' Coefficient Of Variation of (1,664), variance of 99.31, and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide.
At this time, Sangamo Therapeutics' Common Stock Shares Outstanding is very stable compared to the past year. As of the 21st of March 2025, Other Stockholder Equity is likely to grow to about 1.6 B, while Total Stockholder Equity is likely to drop about 21.6 M. . At this time, Sangamo Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 21st of March 2025, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 3.38. Sangamo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of April 2000 | 200 Day MA 1.1549 | 50 Day MA 1.09 | Beta 1.5 |
Sangamo |
Sharpe Ratio = -0.1215
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SGMO |
Estimated Market Risk
| 9.31 actual daily | 83 83% of assets are less volatile |
Expected Return
| -1.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sangamo Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sangamo Therapeutics by adding Sangamo Therapeutics to a well-diversified portfolio.
Price Book 7.9665 | Enterprise Value Ebitda (1.00) | Price Sales 3.029 | Shares Float 218.4 M | Wall Street Target Price 5 |
Sangamo Therapeutics Stock Price History Chart
There are several ways to analyze Sangamo Stock price data. The simplest method is using a basic Sangamo candlestick price chart, which shows Sangamo Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 26, 2024 | 2.63 |
| Lowest Price | March 20, 2025 | 0.84 |
Sangamo Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Sangamo Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sangamo Stock. It can be used to describe the percentage change in the price of Sangamo Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sangamo Stock.| Sangamo Therapeutics Price Action Indicator | (0.05) | |
| Sangamo Therapeutics Price Rate Of Daily Change | 0.97 | |
| Sangamo Therapeutics Price Daily Balance Of Power | (0.30) |
Sangamo Therapeutics March 21, 2025 Stock Price Analysis
Sangamo Stock Price History Data
The price series of Sangamo Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 1.98 with a coefficient of variation of 40.47. The price distribution for the period has arithmetic mean of 1.33. The median price for the last 90 days is 1.13.| Open | High | Low | Close | Volume | ||
03/21/2025 | 0.86 | 0.92 | 0.82 | 0.84 | ||
| 03/20/2025 | 0.86 | 0.92 | 0.82 | 0.84 | 5,428,300 | |
| 03/19/2025 | 0.86 | 0.91 | 0.81 | 0.87 | 8,857,723 | |
| 03/18/2025 | 0.91 | 0.91 | 0.84 | 0.85 | 11,706,663 | |
| 03/17/2025 | 1.00 | 1.04 | 0.97 | 1.01 | 6,746,753 | |
| 03/14/2025 | 0.95 | 1.04 | 0.93 | 0.98 | 3,435,953 | |
| 03/13/2025 | 0.97 | 1.01 | 0.92 | 0.92 | 5,767,973 | |
| 03/12/2025 | 1.00 | 1.05 | 0.96 | 1.00 | 6,202,829 | |
| 03/11/2025 | 0.98 | 1.03 | 0.94 | 0.99 | 3,253,634 | |
| 03/10/2025 | 1.03 | 1.04 | 0.96 | 0.99 | 3,199,456 | |
| 03/07/2025 | 1.06 | 1.06 | 0.96 | 1.04 | 5,251,421 | |
| 03/06/2025 | 0.86 | 1.02 | 0.82 | 1.00 | 4,621,713 | |
| 03/05/2025 | 0.86 | 0.91 | 0.81 | 0.87 | 4,816,060 | |
| 03/04/2025 | 0.90 | 0.91 | 0.80 | 0.86 | 4,263,499 | |
| 03/03/2025 | 1.02 | 1.03 | 0.89 | 0.92 | 3,905,528 | |
| 02/28/2025 | 0.96 | 1.05 | 0.91 | 1.02 | 3,372,205 | |
| 02/27/2025 | 1.00 | 1.04 | 0.95 | 0.96 | 3,641,349 | |
| 02/26/2025 | 0.97 | 1.04 | 0.97 | 0.98 | 3,023,115 | |
| 02/25/2025 | 1.01 | 1.01 | 0.91 | 0.96 | 5,050,950 | |
| 02/24/2025 | 1.08 | 1.08 | 1.00 | 1.00 | 3,846,631 | |
| 02/21/2025 | 1.13 | 1.17 | 1.05 | 1.07 | 4,284,639 | |
| 02/20/2025 | 1.10 | 1.16 | 1.09 | 1.12 | 3,580,610 | |
| 02/19/2025 | 1.16 | 1.17 | 1.10 | 1.10 | 2,899,476 | |
| 02/18/2025 | 1.18 | 1.24 | 1.15 | 1.15 | 2,765,831 | |
| 02/14/2025 | 1.17 | 1.21 | 1.15 | 1.17 | 2,942,262 | |
| 02/13/2025 | 1.14 | 1.19 | 1.11 | 1.17 | 2,839,309 | |
| 02/12/2025 | 1.11 | 1.15 | 1.10 | 1.13 | 2,312,859 | |
| 02/11/2025 | 1.14 | 1.16 | 1.09 | 1.14 | 2,993,134 | |
| 02/10/2025 | 1.19 | 1.19 | 1.07 | 1.16 | 5,159,218 | |
| 02/07/2025 | 1.27 | 1.29 | 1.13 | 1.15 | 5,637,213 | |
| 02/06/2025 | 1.39 | 1.40 | 1.26 | 1.27 | 8,187,902 | |
| 02/05/2025 | 1.24 | 1.28 | 1.22 | 1.26 | 2,182,539 | |
| 02/04/2025 | 1.17 | 1.25 | 1.15 | 1.24 | 2,696,963 | |
| 02/03/2025 | 1.17 | 1.25 | 1.14 | 1.17 | 3,235,214 | |
| 01/31/2025 | 1.25 | 1.29 | 1.18 | 1.23 | 4,031,495 | |
| 01/30/2025 | 1.14 | 1.26 | 1.14 | 1.23 | 6,125,832 | |
| 01/29/2025 | 1.12 | 1.17 | 1.10 | 1.13 | 2,893,842 | |
| 01/28/2025 | 1.13 | 1.15 | 1.08 | 1.13 | 3,250,661 | |
| 01/27/2025 | 1.12 | 1.21 | 1.12 | 1.13 | 3,950,743 | |
| 01/24/2025 | 1.21 | 1.29 | 1.16 | 1.16 | 3,988,481 | |
| 01/23/2025 | 1.13 | 1.22 | 1.11 | 1.19 | 2,824,976 | |
| 01/22/2025 | 1.12 | 1.16 | 1.10 | 1.15 | 3,237,483 | |
| 01/21/2025 | 1.12 | 1.15 | 1.07 | 1.13 | 3,689,037 | |
| 01/17/2025 | 1.10 | 1.14 | 1.08 | 1.09 | 4,332,422 | |
| 01/16/2025 | 1.12 | 1.14 | 1.06 | 1.10 | 4,278,692 | |
| 01/15/2025 | 1.08 | 1.14 | 1.05 | 1.10 | 7,463,732 | |
| 01/14/2025 | 1.12 | 1.18 | 1.00 | 1.02 | 4,688,287 | |
| 01/13/2025 | 1.12 | 1.15 | 1.03 | 1.08 | 6,731,565 | |
| 01/10/2025 | 1.23 | 1.25 | 1.12 | 1.17 | 5,159,123 | |
| 01/08/2025 | 1.35 | 1.37 | 1.20 | 1.22 | 6,006,837 | |
| 01/07/2025 | 1.37 | 1.51 | 1.34 | 1.37 | 7,289,895 | |
| 01/06/2025 | 1.35 | 1.45 | 1.30 | 1.35 | 10,909,770 | |
| 01/03/2025 | 1.13 | 1.33 | 1.12 | 1.30 | 13,397,592 | |
| 01/02/2025 | 1.02 | 1.14 | 0.97 | 1.13 | 13,758,780 | |
| 12/31/2024 | 1.07 | 1.26 | 0.91 | 1.02 | 44,556,129 | |
| 12/30/2024 | 2.49 | 2.50 | 2.32 | 2.34 | 19,169,410 | |
| 12/27/2024 | 2.62 | 2.73 | 2.53 | 2.56 | 4,101,787 | |
| 12/26/2024 | 2.46 | 2.67 | 2.43 | 2.63 | 4,139,508 | |
| 12/24/2024 | 2.32 | 2.50 | 2.29 | 2.50 | 2,521,419 | |
| 12/23/2024 | 2.34 | 2.59 | 2.34 | 2.39 | 6,189,089 | |
| 12/20/2024 | 2.30 | 2.53 | 2.25 | 2.47 | 13,730,330 |
About Sangamo Therapeutics Stock history
Sangamo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sangamo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sangamo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sangamo Therapeutics stock prices may prove useful in developing a viable investing in Sangamo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 201.7 M | 211.8 M | |
| Net Loss | -173.1 M | -164.4 M |
Sangamo Therapeutics Quarterly Net Working Capital |
|
Sangamo Therapeutics Stock Technical Analysis
Sangamo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Sangamo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sangamo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Sangamo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sangamo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | 0.2037 | |||
| Treynor Ratio | (0.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sangamo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.49) | Revenue Per Share | Quarterly Revenue Growth 2.698 | Return On Assets | Return On Equity |
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.